Salvia BioElectronics
We believe that people with migraine deserve to reclaim their life. Salvia BioElectronics is pioneering neuromodulation therapy aiming to transform the migraine treatment landscape.
Salvia BioElectronics has raised €53M across 1 funding round from 9 investors, most recently a Series B round in May 2025. Based in Eindhoven, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Eindhoven, Netherlandswww.salviabioelectronics.com ↗
Total raised
€53M
€52,835,505
Funding rounds
1
Investors
9
distinct backers
Active since
2025-05
latest 2025-05
Funding by year
EUR raised per yearSalvia BioElectronics — funding by year — interactive chart.
Data table
| Salvia BioElectronics — funding by year | |
|---|---|
| 2025 | €53M |
Signals
High confidenceRaise-next likelihood69
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-27 | Series B | €53M | Brabant Development Agency (BOM),Dolby Family Ventures,EIC Fund,INKEF Capital,Innovation Industries,Invest-NL+3 more | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData